Skip to content

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2019-03-31, filed 2019-05-14, with 33 holding rows worth $210,309,000.

Accession
0001493152-19-006979
Filed
2019-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2019

A holdings report, 33 entries on the cover page, a total value of $210,309,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $210,309,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IOVANCE BIOTHERAPEUTICS INC462260100COM2,944,201$27,999,000thousands by filing date
KADMON HLDGS INC48283N106COM7,635,000$20,156,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM760,500$14,974,000thousands by filing date
CAS MED SYS INC124769209COM5,263,508$12,790,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock370,000$10,756,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM206,000$10,603,000thousands by filing date
IMMUNOMEDICS INC452907108COM500,000$9,605,000thousands by filing date
VERACYTE INC COM92337F107Stock381,500$9,545,000thousands by filing date
DERMIRA INC24983L104COM636,500$8,625,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR63,500$7,927,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM517,500$6,872,000thousands by filing date
Viewra, Inc92672L107COM815,000$6,023,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM205,500$5,881,000thousands by filing date
ENANTA PHARMACEUTICALS INC29251M106COM61,000$5,827,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock552,500$5,613,000thousands by filing date
IRIDEX CORP462684101COM1,174,500$5,356,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM328,825$4,817,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock919,000$4,816,000thousands by filing date
ARVINAS INC04335A105COM314,000$4,635,000thousands by filing date
PROTAGONIST THERAPEUTICS74366E102COM337,500$4,242,000thousands by filing date
ALECTOR INC014442107COMMON STOCK200,000$3,744,000thousands by filing date
ACER THERAPEUTICS INC00444P108CMN147,000$3,572,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM167,500$3,074,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM41,000$3,005,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM50,000$2,574,000thousands by filing datecall
QUOTIENT LTDG73268107SHS280,000$2,523,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW87,500$1,817,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock60,000$1,300,000thousands by filing date
ALLAKOS INC01671P100COM13,500$547,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM45,500$518,000thousands by filing date
CHEMBIO DIAGNOSTICS163572209COM41,667$231,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock25,000$204,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK250,000$138,000thousands by filing dateput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-19-006979this filing2019-05-14acceptance time not in the bulk data set